未登录

S

Sabrina M. Ronen

University of California System

H指数:44

被引数:7,071

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Imaging the effects of treatment with TERT and EGFR inhibitors on glioblastoma: An MR study

使用TERT和EGFR抑制剂治疗胶质母细胞瘤的效果成像：一项MR研究

NEURO-ONCOLOGY ADVANCES

IF4.1

2025-01-010

OAAI

Monitoring response to a clinically relevant IDH inhibitor in glioma-Hyperpolarized 13C magnetic resonance spectroscopy approaches

在神经胶质瘤中监测对临床相关IDH抑制剂的反应-超极化13C磁共振波谱方法

NEURO-ONCOLOGY ADVANCES

IF4.1

2023-11-020

OAAI

Hyperpolarized δ-[1-13C]gluconolactone imaging visualizes response to TERT or GABPB1 targeting therapy for glioblastoma

SCIENTIFIC REPORTS

IF3.9

2023-03-302

OAAI

Deuterium Metabolic Imaging Reports on TERT Expression and Early Response to Therapy in Cancer

CLINICAL CANCER RESEARCH

IF10.2

2022-06-098

OA

Imaging biomarkers of TERT or GABPB1 silencing in TERT-positive glioblastoma

IF13.4

2022-04-238

OA

Deuterium magnetic resonance spectroscopy enables noninvasive metabolic imaging of tumor burden and response to therapy in low-grade gliomas

IF13.4

2022-01-2913

OA

Acquisition and quantification pipeline for in vivo hyperpolarized 13C MR spectroscopy

MAGNETIC RESONANCE IN MEDICINE

IF3

2021-11-142

OA

Metabolic imaging detects elevated glucose flux through the pentose phosphate pathway associated with TERT expression in low-grade gliomas

IF13.4

2021-04-1722

OA

Imaging 6-Phosphogluconolactonase Activity in Brain Tumors In Vivo Using Hyperpolarized δ-[1-13C]gluconolactone

FRONTIERS IN ONCOLOGY

IF3.3

2021-04-1510

OAAI

Early Noninvasive Metabolic Biomarkers of Mutant IDH Inhibition in Glioma

胶质瘤中突变型IDH抑制的早期无创代谢生物标志物

IF3.7

2021-02-1317

OAAI

Non-invasive assessment of telomere maintenance mechanisms in brain tumors

NATURE COMMUNICATIONS

IF15.7

2021-01-0422

OAAI

Glutamate Is a Noninvasive Metabolic Biomarker of IDH1-Mutant Glioma Response to Temozolomide Treatment

CANCER RESEARCH

IF16.6

2020-11-1322

OAAI

Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma

来自复发性肿瘤的患者来源的细胞，可模拟IDH突变型神经胶质瘤的进化

NEURO-ONCOLOGY ADVANCES

IF4.1

2020-07-160

OAAI

In vivo detection of γ-glutamyl-transferase up-regulation in glioma using hyperpolarized γ-glutamyl-[1-13C]glycine

SCIENTIFIC REPORTS

IF3.9

2020-04-1016

OAAI

MR-detectable metabolic biomarkers of response to mutant IDH inhibition in low-grade glioma

IF13.3

2020-01-0124

OAAI

PI3K/mTOR inhibition of IDH1 mutant glioma leads to reduced 2HG production that is associated with increased survival

SCIENTIFIC REPORTS

IF3.9

2019-07-1937

OAAI

1H and 13C MRS- based metabolic markers of IDH1 mutant glioma response to temozolomide therapy

CANCER RESEARCH

IF16.6

2019-07-010

PRE

In memoriam: Sarah J. Nelson, January 26, 1954-April 3, 2019

MAGNETIC RESONANCE IN MEDICINE

IF3

2019-05-170

PREAI

In vivo investigation of hyperpolarized [1,3-13C2] acetoacetate as a metabolic probe in normal brain and in glioma

SCIENTIFIC REPORTS

IF3.9

2019-03-0412

OAAI

Hyperpolarized 13C MRI: Path to Clinical Translation in Oncology

超极化13C MRI: 肿瘤学临床转化之路

IF7.7

2019-01-01339

OAAI